|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Pantoloc
Solvay's sales slide and facilities sold to ANI Pharmaceuticals - May 9, 2007 Pharma Times (subscription),Group sales were flat at 2.37 billion euros, while pharmaceutical revenues fell 7% to 625 million euros, due to the expiration of rights to Pantoloc
Solvay posts sound Q1 results exceeding analysts' forecasts - May 8, 2007 Forbes,...reflected the 'unfavourable impact' of the expiration of Pantoloc marketing rights as well as the effect of the usd/eur exhcange rate on American sales.
GERD will not Necessarily Go Away on its Own - Signs and symptoms ... - Mar 29, 2007 CNW Telbec (Communiqués de presse),...(Abbott) - delayed-release capsules - Losec(R) (AstraZeneca) - tablets or capsules - Nexium(R) (AstraZeneca) - tablets - Pantoloc(R) (Altana Pharma,
Group sales flat but pipeline is promising for Solvay - Feb 16, 2007 Pharma Times (subscription),The fourth-quarter decline was principally due to the loss of marketing rights for Pantoloc (pantoprazole) in May and full-year sales of the antiulcerant
Solvay posts forecast-beating rise in FY net profit on higher ... - Feb 15, 2007 Forbes,Werner Cautreels, general manager of pharmaceuticals, said 'pressure on prices' in Europe and the the expiration of the group's Pantoloc marketing rights in
2006 : Another Record Year for Solvay, Due to Strong Growth in ... - Feb 15, 2007 PharmaLive.com (press release),20%) due to the effect of one-off items as announced (inventory reduction by American distributors) and the expiration of marketing rights to Pantoloc®.
Nycomed officially launched as combined group - Jan 16, 2007 CNW Telbec (Communiqués de presse),In 2006 most Nycomed products showed growth, with Pantoloc(R) (pantoprazole sodium), remaining the largest single product by revenue.
Solvay reinforces outsourcing relationship with Lonza - Dec 13, 2006 OutSourcing-Pharma.com,Solvay's pharmaceutical business has come under pressure recently after it lost its patent protection on Pantoloc (pantropzole), one of its top products.
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|